<p>Research support, sponsors, and FDA new drug approvals from 1995 – 2005 for a) infectious disease (non-HIV) research, b) HIV research, c) gastrointestinal research, d) respiratory research, and e) genitourinary research.</p
<p>FDA-Approved NMEs and BLAs and NNE-FDC drugs by Therapeutic Category, 1980–2012.</p
A letter report issued by the Government Accountability Office with an abstract that begins "Before ...
Background: We estimated U.S. biomedical research funding across therapeutic areas, determined the a...
<p>New Molecular Entities Approved by US Food and Drug Administration by Therapeutic Area, 1995–2005...
BackgroundWe estimated U.S. biomedical research funding across therapeutic areas, determined the ass...
A total of 45 new chemical entities had been approved in 1997 by the Food and Drug Administration (F...
Background: We estimated U.S. biomedical research funding across therapeutic areas, determined the a...
<div><p>*Priority NMEs are new molecular entities that represent a significant improvement compared ...
<p>Based on the 432 new molecular entities (with at least one patent) approved by the U.S. Food and ...
Background: The U.S Food and Drugs Administration (FDA) is the world's leading drug regulatory autho...
In the past 12 months, the FDA has approved important new pharmaceutical drugs and devices of partic...
<p>Based on the 432 new molecular entities (with at least one patent) approved by the U.S. Food and ...
Context: Changing evidentiary standards and partial shift of the investigational phase of drug appro...
<p>Total Number of Drugs Approved by US Food and Drug Administration by Therapeutic Area, 1995–2005....
<p>Based on the 342 new molecular entities (with at least one patent) approved by the U.S. Food and ...
<p>FDA-Approved NMEs and BLAs and NNE-FDC drugs by Therapeutic Category, 1980–2012.</p
A letter report issued by the Government Accountability Office with an abstract that begins "Before ...
Background: We estimated U.S. biomedical research funding across therapeutic areas, determined the a...
<p>New Molecular Entities Approved by US Food and Drug Administration by Therapeutic Area, 1995–2005...
BackgroundWe estimated U.S. biomedical research funding across therapeutic areas, determined the ass...
A total of 45 new chemical entities had been approved in 1997 by the Food and Drug Administration (F...
Background: We estimated U.S. biomedical research funding across therapeutic areas, determined the a...
<div><p>*Priority NMEs are new molecular entities that represent a significant improvement compared ...
<p>Based on the 432 new molecular entities (with at least one patent) approved by the U.S. Food and ...
Background: The U.S Food and Drugs Administration (FDA) is the world's leading drug regulatory autho...
In the past 12 months, the FDA has approved important new pharmaceutical drugs and devices of partic...
<p>Based on the 432 new molecular entities (with at least one patent) approved by the U.S. Food and ...
Context: Changing evidentiary standards and partial shift of the investigational phase of drug appro...
<p>Total Number of Drugs Approved by US Food and Drug Administration by Therapeutic Area, 1995–2005....
<p>Based on the 342 new molecular entities (with at least one patent) approved by the U.S. Food and ...
<p>FDA-Approved NMEs and BLAs and NNE-FDC drugs by Therapeutic Category, 1980–2012.</p
A letter report issued by the Government Accountability Office with an abstract that begins "Before ...
Background: We estimated U.S. biomedical research funding across therapeutic areas, determined the a...